Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Cholangiocarcinoma × ivosidenib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 2 Recurrence 1 Myelodysplastic Syndromes 1 Leukemia 1 Hematologic Neoplasms 1 Cholangiocarcinoma 1

Interventions

pembrolizumab 2 pemigatinib 1 ivosidenib 1 entrectinib 1 Gemcitabine 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02989857 2024-08-20

ClarIDHy

Servier

Phase 3 Completed

187 enrolled 34 charts 1 FDA

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡